Amarin Corp Plc (AMRN)

[wikthor]

About BO & Value.

NICE UK guide CVD 2023
https://www.nice.org.uk/guidance/gid-ng10178/documents/draft-guideline-2
https://www.nice.org.uk/guidance/ta805

1.3.51 Do not offer omega 3 fatty acid compounds to prevent CVD to any of the
21 following:
• people who are being treated for primary prevention
• people who are being treated for secondary prevention
• people with CKD
• people with type 1 diabetes
• people with type 2 diabetes.
Icosapent ethyl is an exception to this if used as described in NICE's
technology appraisal guidance on icosapent ethyl with statin therapy forDRAFT FOR CONSULTATION
Cardiovascular disease: NICE guideline DRAFT (January 2023) 21 of 37
reducing the risk of cardiovascular events in people with raised
triglycerides. [2014]

1.3.52 Tell people that there is no evidence that omega 3 fatty acid compounds
help to prevent CVD, except use of icosapent ethyl as described in NICE's
technology appraisal guidance on icosapent ethyl with statin therapy.
[2014]

And the UK wants to introduce statins to the entire population +18 at risk of CVD. Statin Market Rises 7% CAGR and $18B worldwide by 2027 will fall very short.
https://www.tctmd.com/news/uks-nice-recommends-lower-risk-thresholds-statin-therapy

https://news.sky.com/story/statins-boost-for-millions-in-uk-as-study-suggests-fewer-side-effects-than-previously-thought-12543076

One market, one indication. 8 million people objective. 175 pounds/month